2 Indian Firms Seek To End Current Trials Of Merck's Anti-Covid Pill

Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's experimental antiviral drug molnupiravir in moderate COVID-19 patients.

from NDTV News - Topstories https://ift.tt/3iFD1JW